Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Implementing touch-screen technology to enhance recognition of distress.

Clark K, Bardwell WA, Arsenault T, DeTeresa R, Loscalzo M.

Psychooncology. 2009 Aug;18(8):822-30. doi: 10.1002/pon.1509.

PMID:
19085974
2.

Web services-based access to local clinical trial databases: a standards initiative of the Association of American Cancer Institutes.

Stahl DC, Evans RM Jr, Afrin LB, DeTeresa RM, Ko D, Mitchell K.

AMIA Annu Symp Proc. 2003:624-8.

3.

Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.

Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E.

Exp Neurol. 2001 Jul;170(1):15-26.

PMID:
11421580
4.

Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.

Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW Jr, Morris JC.

Neurology. 2001 Jan 9;56(1):127-9.

PMID:
11148253
5.

Changes in pathological findings at autopsy in AIDS cases for the last 15 years.

Masliah E, DeTeresa RM, Mallory ME, Hansen LA.

AIDS. 2000 Jan 7;14(1):69-74.

PMID:
10714569
6.

Comparison of two quantitative methods for the evaluation of neuronal number in the frontal cortex in Alzheimer disease.

Everall IP, DeTeresa R, Terry R, Masliah E.

J Neuropathol Exp Neurol. 1997 Nov;56(11):1202-6.

PMID:
9370230
7.

Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia.

Saitoh T, Kang D, Mallory M, DeTeresa R, Masliah E.

Gerontology. 1997;43(1-2):109-18.

PMID:
8996833
8.

Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L.

Ann Neurol. 1996 Nov;40(5):759-66.

PMID:
8957017
9.

Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.

Xia Y, Rohan de Silva HA, Rosi BL, Yamaoka LH, Rimmler JB, Pericak-Vance MA, Roses AD, Chen X, Masliah E, DeTeresa R, Iwai A, Sundsmo M, Thomas RG, Hofstetter CR, Gregory E, Hansen LA, Katzman R, Thal LJ, Saitoh T.

Ann Neurol. 1996 Aug;40(2):207-15.

PMID:
8773602
10.

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease.

Iwai A, Masliah E, Sundsmo MP, DeTeresa R, Mallory M, Salmon DP, Saitoh T.

Brain Res. 1996 May 13;720(1-2):230-4.

PMID:
8782917
11.

Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease.

Jin LW, Masliah E, Iimoto D, Deteresa R, Mallory M, Sundsmo M, Mori N, Sobel A, Saitoh T.

Neurobiol Aging. 1996 May-Jun;17(3):331-41.

PMID:
8725893
12.

Patterns of neurodegeneration in HIV encephalitis.

Masliah E, Ge N, Achim CL, DeTeresa R, Wiley CA.

J NeuroAIDS. 1996;1(1):161-73. Review. No abstract available.

PMID:
16873160
13.

The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease.

Chen X, Xia Y, Alford M, DeTeresa R, Hansen L, Klauber MR, Katzman R, Thal L, Masliah E, Saitoh T.

Ann Neurol. 1995 Oct;38(4):653-8.

PMID:
7574463
14.

PDGF is associated with neuronal and glial alterations of Alzheimer's disease.

Masliah E, Mallory M, Alford M, Deteresa R, Saitoh T.

Neurobiol Aging. 1995 Jul-Aug;16(4):549-56.

PMID:
8544904
15.

Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia.

Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E.

Arch Neurol. 1994 Aug;51(8):772-8.

PMID:
8042925
16.

Synaptic and neuritic alterations during the progression of Alzheimer's disease.

Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R.

Neurosci Lett. 1994 Jun 6;174(1):67-72.

PMID:
7970158
17.

Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.

Masliah E, Mallory M, Deerinck T, DeTeresa R, Lamont S, Miller A, Terry RD, Carragher B, Ellisman M.

J Neuropathol Exp Neurol. 1993 Nov;52(6):619-32.

PMID:
8229081
18.

Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies.

Masliah E, Mallory M, DeTeresa R, Alford M, Hansen L.

Brain Res. 1993 Jul 23;617(2):258-66.

PMID:
8402154
19.

An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease.

Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R.

Am J Pathol. 1993 Mar;142(3):871-82.

20.

Quantitative synaptic alterations in the human neocortex during normal aging.

Masliah E, Mallory M, Hansen L, DeTeresa R, Terry RD.

Neurology. 1993 Jan;43(1):192-7.

PMID:
8423884
21.

Spectrum of human immunodeficiency virus-associated neocortical damage.

Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA.

Ann Neurol. 1992 Sep;32(3):321-9.

PMID:
1416802
22.

Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease.

Masliah E, Ellisman M, Carragher B, Mallory M, Young S, Hansen L, DeTeresa R, Terry RD.

J Neuropathol Exp Neurol. 1992 Jul;51(4):404-14.

PMID:
1619440
23.

Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease.

Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R, Baudier J, Saitoh T.

Brain Res. 1992 Mar 6;574(1-2):312-6.

PMID:
1386275
24.

Cortical dendritic pathology in human immunodeficiency virus encephalitis.

Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA.

Lab Invest. 1992 Mar;66(3):285-91.

PMID:
1538584
25.

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R.

Ann Neurol. 1991 Oct;30(4):572-80.

PMID:
1789684
26.

Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat.

Masliah E, Fagan AM, Terry RD, DeTeresa R, Mallory M, Gage FH.

Exp Neurol. 1991 Aug;113(2):131-42.

PMID:
1831150
27.

Neocortical damage during HIV infection.

Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R.

Ann Neurol. 1991 Jun;29(6):651-7.

PMID:
1909852
28.

Patterns of aberrant sprouting in Alzheimer's disease.

Masliah E, Mallory M, Hansen L, Alford M, Albright T, DeTeresa R, Terry R, Baudier J, Saitoh T.

Neuron. 1991 May;6(5):729-39.

PMID:
1827266
29.

Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?

Masliah E, Hansen LA, Quijada S, DeTeresa R, Alford M, Kauss J, Terry R.

Ann Neurol. 1991 Apr;29(4):389-96.

PMID:
1929210
30.

Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA.

Am J Pathol. 1991 Jan;138(1):235-46.

31.

Differential involvement of protein kinase C isozymes in Alzheimer's disease.

Masliah E, Cole G, Shimohama S, Hansen L, DeTeresa R, Terry RD, Saitoh T.

J Neurosci. 1990 Jul;10(7):2113-24.

32.
33.

Aberrant casein kinase II in Alzheimer's disease.

Iimoto DS, Masliah E, DeTeresa R, Terry RD, Saitoh T.

Brain Res. 1990 Jan 22;507(2):273-80.

PMID:
2337767
34.

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, et al.

Neurology. 1990 Jan;40(1):1-8.

PMID:
2153271
35.

Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.

Masliah E, Terry RD, DeTeresa RM, Hansen LA.

Neurosci Lett. 1989 Aug 28;103(2):234-9.

PMID:
2505201
36.

An antiserum against amyloid beta-protein precursor detects a unique peptide in Alzheimer brain.

Cole G, Masliah E, Huynh TV, DeTeresa R, Terry RD, Okuda C, Saitoh T.

Neurosci Lett. 1989 May 22;100(1-3):340-6.

PMID:
2503790
37.

Neocortical morphometry and cholinergic neurochemistry in Pick's disease.

Hansen LA, Deteresa R, Tobias H, Alford M, Terry RD.

Am J Pathol. 1988 Jun;131(3):507-18.

38.

Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A.

Ann Neurol. 1988 Feb;23(2):138-44.

PMID:
2897823
39.

Peptide radioimmunoassays: a BASIC program for data reduction.

Tobias H, Deteresa RM.

Brain Res Bull. 1988 Jan;20(1):125-8.

PMID:
3342337
40.
41.

Response of septal cholinergic neurons to axotomy.

Armstrong DM, Terry RD, Deteresa RM, Bruce G, Hersh LB, Gage FH.

J Comp Neurol. 1987 Oct 15;264(3):421-36.

PMID:
3680637
42.

Neocortical cell counts in normal human adult aging.

Terry RD, DeTeresa R, Hansen LA.

Ann Neurol. 1987 Jun;21(6):530-9.

PMID:
3606042
43.

Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles.

Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R.

J Neuropathol Exp Neurol. 1987 May;46(3):262-8.

PMID:
2881985
44.

Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies.

Horoupian DS, Thal L, Katzman R, Terry RD, Davies P, Hirano A, DeTeresa R, Fuld PA, Petito C, Blass J, et al.

Ann Neurol. 1984 Sep;16(3):305-13.

PMID:
6148912
45.

Deafness in Cockayne's syndrome: morphological, morphometric, and quantitative study of the auditory pathway.

Gandolfi A, Horoupian D, Rapin I, DeTeresa R, Hyams V.

Ann Neurol. 1984 Feb;15(2):135-43.

PMID:
6703654
46.
47.

Some morphometric aspects of the brain in senile dementia of the Alzheimer type.

Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS.

Ann Neurol. 1981 Aug;10(2):184-92.

PMID:
7283403

Supplemental Content

Loading ...
Support Center